We cordially invite you to attend the Umeå Infection Symposium on Friday 29 May 2026. Get inspired by the invited keynote speaker and learn about novel research approaches and directions at Umeå University. The registration deadline is Friday 8 May.
There is plenty of time to network at the Umeå Infection Symposium.
ImageMattias Pettersson
Welcome to the symposium!
The symposium is aimed for all scientists and staff members interested in microbial and infection research. The event is jointly organized by the Laboratory for Molecular Infection Medicine Sweden, MIMS, and Umeå Microbial Research Centre, UCMR, at Umeå University.
The scientific symposium takes place on Friday 29 May at 9:15-14:30, including a pre-event coffee from 8:45, and a lunch that gives all participants the opportunity to mingle and continue the scientific discussions. In the afternoon, we invite all participants for coffee and cake.
The venue for the symposium is Rex in the City hall in Umeå (Rådhusesplanaden 2A).
Confirmed keynote speaker
ImageMatt Wong
Sam Sternberg, Ph.D Associate Professor, Howard Hughes Medical Institute, Columbia University
Abstract: Bacteria deploy diverse antiviral systems to defend against foreign pathogens, including CRISPR–Cas nucleases that use guide RNAs to target DNA cleavage, establishing RNA-guided immunity as a central paradigm. Our recent work uncovered a complementary strategy: defense-associated reverse transcriptases (DRTs) that use template RNAs to direct DNA synthesis during phage infection. DRT2 and DRT9 systems generate distinct DNA products — de novo genes and toxic homopolymers through unconventional reverse transcription mechanisms. More recently, we identified DRT10, which catalyzes protein-primed, RNA-templated synthesis of tandem-repeat DNA via a structured ncRNA. This repeat addition mechanism closely parallels telomerase, with shared requirements for template boundary definition and iterative realignment during DNA synthesis. Phylogenetic and structural analyses suggest that telomerase evolved from bacterial DRT-like enzymes, revealing an unexpected evolutionary link between antiviral immunity and eukaryotic chromosome maintenance. Together, these findings expand RNA-guided immunity beyond CRISPR and establish reverse transcription as a broadly conserved strategy for nucleic acid-based defense.